Mgr. Adam Svobodník, Ph.D.
Researcher, CZECRIN - Large Research Infrastructure
Correspondence Address:
Palachovo nám. 726/3, 625 00 Brno
E‑mail: |
---|
Total number of publications: 142
2020
-
Workshop StrokeCzech - Organizace akademických klinických studií
Year: 2020, type:
2017
-
Raising standards in clinical research - The impact of the ECRIN data centre certification programme, 2011-2016
Year: 2017, type: Article in Periodical (without peer review)
2009
-
Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis
Multiple sclerosis, year: 2009, volume: 15, edition: 8
-
Trendy chirurgické léčby nemalobuněčného bronchogenního karcinomu v letech 2000-2006
Studia Pneumologica et Phthiseologica, year: 2009, volume: 69, edition: 2
-
Výsledky klinického hodnocení účinnosti a toxicity gefitinibu v rámci programu časného přístupu u nemalobuněčného karcinomu plic v České republice
Studia Pneumologica et Phthiseologica, year: 2009, volume: 69, edition: 2
2008
-
Adjuvantná systémová liečba karcinómu prsníka-zhodnotenie účinnosti a toxicity
Year: 2008, type: Appeared in Conference without Proceedings
-
Colorectal Cancer Screening Program in the Czech Republic
Year: 2008, type: Appeared in Conference without Proceedings
-
Efficacy of pegylated interferon alpha-2a and ribavirin treatment in chronic hepatitis C patients depends on various baseline parameters and early viral kinetics.
Year: 2008, type: Conference abstract
-
Efficacy of pegylated interferon alpha-2a and ribavirin treatment in chronic hepatitis C patients depends on various baseline parameters and early viral kinetics.
Year: 2008, type: Appeared in Conference without Proceedings
-
Efficacy of pegylated interferon alpha-2a and ribavirin treatment in chronic hepatitis C patients depends on various baseline parameters and early viral kinetics.
International Journal of Infectious Diseases, year: 2008, volume: 12, edition: Suppl. 1